DK1974746T3 - Anvendelse af en adjuvansholdig allergivaccineformulering til parenteral administration - Google Patents

Anvendelse af en adjuvansholdig allergivaccineformulering til parenteral administration

Info

Publication number
DK1974746T3
DK1974746T3 DK08153545.2T DK08153545T DK1974746T3 DK 1974746 T3 DK1974746 T3 DK 1974746T3 DK 08153545 T DK08153545 T DK 08153545T DK 1974746 T3 DK1974746 T3 DK 1974746T3
Authority
DK
Denmark
Prior art keywords
vaccine formulation
parenteral administration
adjuvant
allergy vaccine
allergen
Prior art date
Application number
DK08153545.2T
Other languages
English (en)
Inventor
Eike Gunther Wuestenberg
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38093538&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1974746(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Application granted granted Critical
Publication of DK1974746T3 publication Critical patent/DK1974746T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK08153545.2T 2007-03-28 2008-03-28 Anvendelse af en adjuvansholdig allergivaccineformulering til parenteral administration DK1974746T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90731707P 2007-03-28 2007-03-28
EP07105094A EP1974745B1 (en) 2007-03-28 2007-03-28 Use of an adjuvanted allergy vaccine formulation for subcutaneous administration

Publications (1)

Publication Number Publication Date
DK1974746T3 true DK1974746T3 (da) 2012-04-10

Family

ID=38093538

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07105094.2T DK1974745T3 (da) 2007-03-28 2007-03-28 Anvendelse af en adjuvansholdig allergivaccineformulering til subkutan administration
DK08153545.2T DK1974746T3 (da) 2007-03-28 2008-03-28 Anvendelse af en adjuvansholdig allergivaccineformulering til parenteral administration

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07105094.2T DK1974745T3 (da) 2007-03-28 2007-03-28 Anvendelse af en adjuvansholdig allergivaccineformulering til subkutan administration

Country Status (5)

Country Link
US (1) US20120141536A1 (da)
EP (1) EP1974745B1 (da)
AT (2) ATE522228T1 (da)
DK (2) DK1974745T3 (da)
ES (2) ES2370043T3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012392291B2 (en) * 2012-10-19 2017-12-07 Hal Allergy Holding B.V. Compositions for immunotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
US8491909B2 (en) * 2004-02-06 2013-07-23 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
JP2007524096A (ja) 2004-02-26 2007-08-23 アルカベロ アクチェセルスカプ 粘膜投与用ワクチンの治療可能性の評価方法
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration

Also Published As

Publication number Publication date
DK1974745T3 (da) 2011-11-28
EP1974745B1 (en) 2011-08-31
ATE522228T1 (de) 2011-09-15
US20120141536A1 (en) 2012-06-07
ATE540691T1 (de) 2012-01-15
ES2380172T3 (es) 2012-05-09
ES2370043T3 (es) 2011-12-12
EP1974745A1 (en) 2008-10-01

Similar Documents

Publication Publication Date Title
CY1122466T1 (el) Σκευασμα αντισωματος αντι il-17ra και θεραπευτικα σχηματα για την αγωγη της ψωριασης
CY1123476T1 (el) Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
CY1124000T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
HRP20201165T1 (hr) Uporaba inhibitora ccr3
EA201391236A1 (ru) Новые циклические производные азабензимидазола, используемые в качестве антидиабетических агентов
AR088622A1 (es) 18-METIL-6,7-METILEN-3-OXO-17-PREGN-4-EN-21,17b-CARBOLACTONA, PREPARADOS FARMACEUTICOS QUE CONTIENEN LOS COMPUESTOS MENCIONADOS Y SU USO EN LA TERAPIA DE LA ENDOMETRIOSIS
BR112015026325A2 (pt) dosagem oral de compostos glp-1
BRPI0914682B8 (pt) compostos de heteroarila e composições compreendendo os referidos compostos
BR112014012815A8 (pt) derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença
BR112012018345A2 (pt) "compostos de heteroarila, bem como composições e usos dos mesmos"
ECSP14013312A (es) Composiciones para el tratamiento de vhc
CO6280490A2 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
CL2014000428A1 (es) Metodo para el tratamiento de hepatitis c (hcv) que comprende administrar un compuesto de formula (i), (ii) o (iii) en combinacion con uno o mas agentes terapeuticos; composicion farmaceutica.
BRPI1009637A2 (pt) composto, composição e uso de um composto
EA201070544A1 (ru) Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
CL2014001437A1 (es) Compuestos derivados de aril dihidropiridinona y piperidinona como inhibidores de monoacilglicerol aciltransferasa (mgat2); composicion y combinacion farmaceutica; y uso en el tratamiento y prevencion de diabetes, hiperglucemia, retinopatia, sindrome metabolico, entre otras enfermedades.
CO6410279A2 (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
BR112014013108A2 (pt) compostos tricíclicos fundidos como inibidores da quinase raf
EA201190296A1 (ru) Дисахариновая, дифумарово-кислая, ди-1-гидрокси-2-нафтойно-кислая и монобензойно-кислая соли 4-(диметиламино)бутил-2-(4-((2-амино-4-метил-6-(пентиламино)пиримидин-5-ил)метил)фенил)ацетата
BR112014031310A2 (pt) anticorpos anti-pcsk9, formulações, dosagem e métodos de uso
PE20191655A1 (es) Combinaciones farmaceuticas
BR112014027117A2 (pt) derivados de pirazol aminopirimidina como moduladores de lrrk2 para uso no tratamento de doença de parkinson
CL2014000849A1 (es) Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas.
BR112012027197A2 (pt) combinação ou composição farmacêutica, seu uso, kit, e compostos para tratamento de doenças oncológicas e fibróticas
ES2445846R1 (es) Una composición de combinación farmacéutica y su uso para preparar un medicamento destinado al tatamiento de la diabetes de tipo l y los trastornos metabólicos